Sabby Capital: Funding, Team & Investors | Startup Intros

Loading organizations...

Sabby Capital: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Apr 1, 2017	Epic Sciences	$40.0M Series D	Jerry Xiao	Deerfield Management, Domain Associates, Altos Capital Partners, Frederic Pla, Pagoda Investment, Reach Tone Limited, RusnanoMedInvest, VI Ventures
Jan 6, 2015	Global Blood Therapeutics	$48.0M Series B	—	William Slattery, Perceptive Life Sciences, RA Capital Management, Wellington Management
Dec 1, 2014	Naurex	$80.0M Series C	—	ALSA Ventures, Soffinova Partners, Adams Street Partners, Baxter Ventures, Cowen Healthcare Investments, Druid BioVentures, Oleg Nodelman, Genesys Capital, Goudy Park Capital, H. Lundbeck, Latterell Venture Partners, Northwestern University, Portola Capital Partners, Savitr Capital, Takeda Ventures
Nov 12, 2014	Blueprint Medicines	$50.0M Series C	Alex Virgilio	BVF Partners, Casdin Capital, Cowen Healthcare Investments, F-Prime Capital, Nextech Invest, Perceptive Advisors, RA Capital Management, Redmile Group, Tavistock Group, Third Rock Ventures, Wellington Management
Aug 27, 2014	Bellicum Pharmaceuticals	$55.0M Series C	—	AJU IB Investment, AVG Ventures, Jennison Associates, Joseph Edelman, RA Capital Management, Redmile Group, Remeditex Ventures, Ridgeback Capital Investments
Aug 1, 2014	Dermira	$51.0M Series C	—	Canaan Partners, MPM Capital, Pivotal bioVenture Partners, SR One Capital Management, Aisling Capital, Apple Tree Partners, Bay City Capital, Canaan Partners, New Enterprise Associates, Rock Springs Capital, UCB Ventures
Apr 1, 2014	Adverum Biotechnologies	$55.0M Series B	—	Venrock, Adage Capital Management, Cowen Healthcare Investments, Deerfield Management, Redmile Group, Rock Springs Capital